Oestrogen receptor-positive breast cancer
Disease1 paper5 findings
- Humans1
Upstream
1C-reactive protein
no changein humans1RR 1.03
1 study
C-reactive protein
no changein humans1RR 1.03
C-reactive protein has no effect on oestrogen receptor-positive breast cancer in humans (RR 1.03 (0.95, 1.11)).
Humansbloodfemalesn = 1,223
Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis · British journal of cancer · 19 Sep 2026
Associations
4TNF-alpha
no changein humans1RR 1.27
1 study
TNF-alpha
no changein humans1RR 1.27
TNF-alpha is associated with oestrogen receptor-positive breast cancer in humans (RR: 1.27, 95% CI: 0.96, 1.68).
Humansbloodfemalesn = 1,223
Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis · British journal of cancer · 19 Sep 2026
Adiponectin
no changein humans1RR 1.1
1 study
Adiponectin
no changein humans1RR 1.1
Adiponectin is associated with oestrogen receptor-positive breast cancer in humans (RR: 1.10, 95% CI: 0.90, 1.34).
Humansbloodfemalesn = 1,223
Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis · British journal of cancer · 19 Sep 2026
IL-10
upin humans1RR 1.14
1 study
IL-10
upin humans1RR 1.14
IL-10 raises the risk of oestrogen receptor-positive breast cancer in humans (RR: 1.14, 95% CI: 1.01, 1.29).
Humansbloodfemalesn = 1,223
Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis · British journal of cancer · 19 Sep 2026
Leptin
upin humans1RR 1.13
1 study
Leptin
upin humans1RR 1.13
Leptin raises the risk of oestrogen receptor-positive breast cancer in humans (RR: 1.13, 95% CI: 1.03, 1.25).
Humansbloodfemalesn = 1,223
Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis · British journal of cancer · 19 Sep 2026